Inadequate preparation reduces visualization of diverticular stigmata
Rapid PEG preparation (4 L in 3–4 hours) preferred over split-dose in acute setting
Endoscopic hemostasis evidence
Endoscopic band ligation (EBL) may be superior to clipping for diverticular bleeding
Early rebleed rate 8% vs 19% with clipping
Late rebleed rate 9% vs 29% with clipping
EBL technically feasible in both right and left colon diverticula
Stigmata of recent hemorrhage (SRH) identification guides treatment
Active bleeding, visible vessel, or adherent clot = SRH present
Treatment of SRH reduces recurrent bleeding compared to observation
Tranexamic acid evidence
HALT-IT trial: tranexamic acid did not reduce death or need for transfusion in GI bleed
Associated with increased thromboembolic events and seizure risk
Should not be used in lower gastrointestinal bleeding (ACG 2023 guideline)
Diverticular rebleed prevention
No pharmacologic agent proven to prevent recurrent diverticular bleeding
Mesalazine, rifaximin: no strong evidence for rebleed prevention
High-fiber diet supports general colonic health but not proven to prevent rebleed
Minimize antithrombotic exposure where clinically appropriate
Discontinue aspirin for primary prevention permanently after diverticular bleed
Resume antithrombotics for secondary cardiovascular prevention at earliest safe opportunity
Patient Discharge Instructions
copy discharge instructions
Home care instructions
Activity: rest for 24–48 hours after discharge
Light activity as tolerated once feeling better
Avoid heavy lifting or strenuous exercise for 1 week
Diet
Clear liquids initially, advance as tolerated
High-fiber diet once tolerating solid foods
Adequate hydration: 6–8 glasses of water daily
Medications
Take all prescribed medications as directed
Avoid NSAIDs (ibuprofen, naproxen, diclofenac) unless specifically directed by your doctor
Do not restart aspirin for primary prevention without discussing with your doctor
If on anticoagulants, do not restart until instructed by your physician
Warning signs requiring immediate return to ER
Return immediately for recurrence of blood in stool (any amount)
Bright red blood, dark red blood, or maroon-colored stool
Passage of blood clots
Lightheadedness, dizziness, or fainting
Rapid heart rate or palpitations
Weakness or inability to stand
Chest pain or shortness of breath
New or worsening abdominal pain
Significant nausea or vomiting preventing hydration
Fever above 38.5 C (101.3 F)
Decreased urine output or signs of dehydration
Follow-up instructions
Outpatient colonoscopy within 14 days if not performed during hospital stay
Contact your gastroenterologist's office within 2–3 days to arrange booking
Do not delay colonoscopy appointment
Family doctor follow-up within 1–2 weeks
Repeat blood count at follow-up visit
Medication review with your doctor
Recurrence is common (approximately 15% at 1 year, 25% at 5 years)
Importance of colonoscopy surveillance to ensure no other colon pathology
Ensure colon cancer screening is up to date
References
Guidelines and key sources
ACG guidelines
Sengupta N, Feuerstein JD, Jairath V, et al. Management of Patients With Acute Lower Gastrointestinal Bleeding: An Updated ACG Guideline. Am J Gastroenterol. 2023
Oakland score validation and use for LGIB risk stratification
Colonoscopy timing, endoscopic hemostasis, and antithrombotic management
ACR Appropriateness Criteria: Radiologic Management of Lower Gastrointestinal Tract Bleeding: 2021 Update. Karuppasamy K et al. J Am Coll Radiol. 2021
CTA as first-line imaging for hemodynamically significant LGIB
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.